Tevogen (TVGN) Interest Coverage Ratio (2023 - 2025)
Tevogen Bio Holdings' (TVGN) quarterly Interest Coverage Ratio came in at 0.24 in Q4 2025, up 97.63% YoY from 0.12 in Q4 2024, and up 99.94% on a QoQ basis from 421.49 in Q1 2025.
Tevogen (TVGN) Interest Coverage Ratio (2023 - 2025) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 3 years of Interest Coverage Ratio data on file, last reported at 0.24 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 97.63% year-over-year to 0.24 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 862.2 (down 2270.56% YoY) and the FY2025 annual result came in at 1.38, up 97.22% from the prior year.
- Interest Coverage Ratio grew to 0.24 in Q4 2025, from 421.49 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.24 in Q4 2025 to a low of 488.44 in Q3 2024.
- A 3-year average of 141.51 and a median of 9.17 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio tumbled 6201.29% — and 2025, when it soared 97.63%.
- Tracing TVGN's Interest Coverage Ratio over 3 years: stood at 6.33 in 2023, then slumped by 62.8% to 10.3 in 2024, then soared by 97.63% to 0.24 in 2025.
- The last three Interest Coverage Ratio figures came in at 0.24 (Q4 2025), 421.49 (Q1 2025), and 10.3 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.42 |
| 10 | Tevogen | 25.73 Mn | 25.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.24 |
| Mar 31, 2025 | -421.49 |
| Dec 31, 2024 | -10.30 |
| Sep 30, 2024 | -488.44 |
| Mar 31, 2024 | -189.47 |
| Dec 31, 2023 | -6.33 |
| Sep 30, 2023 | -7.75 |
| Mar 31, 2023 | -8.04 |